Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quantification of Free Circulating DNA As a Diagnostic Marker in Lung Cancer

30 Sept 2003

Abstract excerpt

PURPOSE: Analysis of circulating DNA in plasma can provide a useful marker for earlier lung cancer detection. This study was designed to assess the sensitivity and specificity of a quantitative molecular assay of circulating DNA to identify patients with lung cancer and monitor their disease. MATERIALS AND METHODS: The amount of plasma DNA was determined through the use of real-time quantitative polymerase chain...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Research Studies
Share to Multiple and Secondary Primary Cancers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14507943
DOI: 10.1200/jco.2003.02.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quantification of Free Circulating DNA As a Diagnostic Marker in Lung CancerPMID 14507943Read ↗

Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.Semantic proximity Read ↗

Circulating DNA and lung cancer.Semantic proximity Read ↗

Circulating DNA addresses cancer monitoring in non small cell lung cancer patients for detection and capturing the dynamic changes of the diseaseSemantic proximity Read ↗

Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectivesSemantic proximity Read ↗

Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancerSemantic proximity Read ↗

Circulating Cell-Free DNA in Plasma/Serum of Lung Cancer Patients as a Potential Screening and Prognostic ToolSemantic proximity Read ↗

Cell-free circulating tumor DNA in plasma/serum of non-small cell lung cancer.Semantic proximity Read ↗

Comparison of Circulating Plasma DNA Levels between Lung Cancer Patients and Healthy ControlsSemantic proximity Read ↗

Quantification of concentration and assessment of EGFR mutation in circulating DNA.Semantic proximity Read ↗

Quantification of Free Circulating Tumor DNA as a Diagnostic Marker for Breast CancerSemantic proximity Read ↗

Circulating DNA: Diagnostic Tool and Predictive Marker for Overall Survival of NSCLC PatientsSemantic proximity Read ↗

Quantitative Analysis of Circulating Plasma DNA as a Tumor Marker in Thoracic MalignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.